Factors prohibiting progression to prostanoid therapy in patients with pulmonary arterial hypertension and CTEPH who remain in functional class III or above despite maximal oral therapy
Effects of sildenafil in patients with persistent pulmonary hypertension after left prosthetic valvular replacement at rest and during dobutamine stress according to the hemodynamic phenotype
Speaker:
Associate Professor R. Aguilar Torres (Madrid, ES)
Initial combination with bosentan and sildenafil as compared with initial monotherapy with the same drugs in patients with pulmonary arterial hypertension: a case-control, multicentre study
Effect of calcium channel blockers on exercise capacity in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing